pamidronate has been researched along with Central Nervous System Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saenger, P | 1 |
| Rincon, M | 1 |
| Bayram, F | 1 |
| Tanriverdi, F | 1 |
| Kurtoğlu, S | 1 |
| Atabek, ME | 1 |
| Kula, M | 1 |
| Kaynar, L | 1 |
| Keleştimur, F | 1 |
2 other studies available for pamidronate and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Precocious puberty: McCune-Albright syndrome and beyond.
Topics: Anti-Inflammatory Agents; Central Nervous System Neoplasms; Child; Child, Preschool; Diphosphonates; | 2003 |
Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
Topics: Abnormalities, Multiple; Adolescent; Adult; Bone Density; Bone Density Conservation Agents; Central | 2006 |